Eastman J R, Bixler D
J Craniofac Genet Dev Biol. 1983;3(3):213-34.
This article presents detailed clinical and laboratory investigations of six hypophosphatasia kindreds. Serum alkaline phosphatase and urinary phosphoethanolamine comparisons between the affected population and a normal control population demonstrate these parameters routinely identify the heterozygous individual when age and sex variations are accounted for. Using clinical data from the kindred population and a detailed review of the literature, the type and frequency of clinical findings for both the homozygous and heterozygous genotype are enumerated. The clinical and biochemical phenotypes were subjected to segregation analysis. When the results of these analyses are viewed in light of their mathematical limitations and the genetic precepts of autosomal dominant and recessive inheritance, hypophosphatasia is best described as an autosomal dominant disorder with 85% penetrance and homozygous lethality.
本文介绍了对六个低磷酸酯酶症家族的详细临床和实验室研究。通过比较患病人群和正常对照人群的血清碱性磷酸酶及尿磷酸乙醇胺,发现当考虑年龄和性别差异时,这些参数通常能够识别出杂合个体。利用家族人群的临床数据并详细回顾文献,列举了纯合子和杂合子基因型的临床发现类型及频率。对临床和生化表型进行了分离分析。鉴于这些分析结果在数学上的局限性以及常染色体显性和隐性遗传的遗传学规律,低磷酸酯酶症最好被描述为一种常染色体显性疾病,其外显率为85%,纯合子致死。